Login / Register The Most Trusted Name in Medical Education

Surgery

Improve your knowledge in the field of surgery by taking one of Elsevier's complimentary continuing medical education courses.

Bladder Cancer banner 116x140

Management of Patients with Bladder Cancer, Elsevier CME Independent Conference Highlights of the ASCO-GU Genitourinary Cancer Symposiums 2018*

Format: Webcast

This conference reporter webcast on bladder cancer is based on a roundtable discussion by three experts. During the webcast they provide an overview of challenges in the management of bladder cancer and summarize and discuss recent data presented during the ASCO-GU 2018 Symposium. The experts examine clinical trial outcomes of immunotherapies for bladder cancer and address the question of how current, novel, and emerging treatment options (when approved) could be implemented in individualized treatment plans to optimize treatment selection and outcomes for patients with bladder cancer.

*This webcast is not endorsed by the conference organizer. The Elsevier Office of Continuing Medical Education is an independent medical education company that provides clinical updates, analysis, and expert perspectives through conference-coverage educational programs.

Take Course »

Credits: 1.0 AMA PRA Category 1 Credit™
Colorectal Cancer banner 116x140

Management of Patients with Colorectal Cancer, Elsevier CME Independent Conference Highlights of the ASCO-GI 2018 Annual Meeting*

Format: Webcast

*This webcast is not endorsed by the conference organizer. The Elsevier Office of Continuing Medical Education is an independent medical education company that provides clinical updates, analysis, and expert perspectives through conference-coverage educational programs.

This conference reporter webcast on colorectal cancer is based on a roundtable discussion by three experts. During the webcast they provide an overview of challenges in the management of colorectal cancer and summarize and discuss recent data presented during the ASCO-GI 2018 Symposium. The experts examine clinical trial outcomes of targeted therapies for colorectal cancer and address the question of how current, novel, and emerging treatment options (when approved) could be implemented in individualized treatment plans to optimize treatment selection and outcomes for patients with colorectal cancer.

Credits: 1.0 AMA PRA Category 1 Credit™
910752 116 x 140

ESMO 2017: A Therapeutic Update on the Management of Patients with Advanced Hepatocellular Carcinoma

Format: Medical Meeting Reporter

This webcast on hepatocellular carcinoma (HCC) is based on a presentation by an expert, who provides an overview of the advances in the management of HCC and summarizes and discusses the latest data presented during the European Society for Medical Oncology (ESMO) Annual Meeting 2017, held on September 8-12 in Madrid, Spain. Results of clinical trials of targeted therapies that have been evaluated in first-line and second-line setting in advanced HCC and their possible effect on treatment guidelines will be examined. Additionally, the potential role of biomarkers as prognostic factors of response to targeted therapies, particularly in clinical practice, will also be discussed. The expert will also discuss the most promising new agents in advanced clinical trials in HCC and how they might impact the treatment landscape in HCC.

Take Course »

 

Credits: 1.0 AMA PRA Category 1 Credit™
910711 116 x 140

Real-world Experience With Neuromuscular Blockade Reversal

Format: Webcast

 Neuromuscular blocking agents (NMBAs) are used in many surgical procedures and have enabled new surgical advances. The expanded landscape of NMB reversal drugs allows for fast and complete neuromuscular blockade (NMB) reversal and the reduction of postoperative complications from residual block. In the United States, neostigmine/ glycopyrrolate and sugammadex are the primary agents for pharmacologic antagonism of NMBAs. While neostigmine and an anticholinergic have been available for decades, sugammadex has only recently become available. We present real-world cases in a variety of surgeries and clinical settings in which the use of NMB reversal agents played a significant role in the patients clinical outcome.

Take Course »

Credits: 1.00 AMA PRA Category 1 Credit(s)™